| # | Title | Journal | Year | Citations |
|---|
| 1 | Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients | Transplant Infectious Disease | 2010 | 382 |
| 2 | Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century | Transplant Infectious Disease | 1999 | 256 |
| 3 | Identifying the patient at risk for post-transplant lymphoproliferative disorder | Transplant Infectious Disease | 2001 | 229 |
| 4 | European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL‐4 (2011) | Transplant Infectious Disease | 2012 | 224 |
| 5 | The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants | Transplant Infectious Disease | 2002 | 205 |
| 6 | Outcome of treatment of Epstein–Barr virus‐related post‐transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases | Transplant Infectious Disease | 2009 | 194 |
| 7 | Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy | Transplant Infectious Disease | 2010 | 157 |
| 8 | Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON�-CMV | Transplant Infectious Disease | 2007 | 154 |
| 9 | Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease | Transplant Infectious Disease | 2001 | 150 |
| 10 | Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients | Transplant Infectious Disease | 2005 | 149 |
| 11 | Acute graft pyelonephritis following renal transplantation | Transplant Infectious Disease | 2006 | 145 |
| 12 | Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort | Transplant Infectious Disease | 2012 | 140 |
| 13 | Infection with Klebsiella pneumoniae carbapenemase (KPC)‐producing K. pneumoniae in solid organ transplantation | Transplant Infectious Disease | 2012 | 139 |
| 14 | Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center | Transplant Infectious Disease | 2005 | 136 |
| 15 | Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity | Transplant Infectious Disease | 2009 | 136 |
| 16 | The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant‐Associated Infection Surveillance Network (TRANSNET) | Transplant Infectious Disease | 2016 | 135 |
| 17 | Safety and tolerability of caspofungin acetate in the treatment of fungal infections | Transplant Infectious Disease | 2002 | 134 |
| 18 | Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant‐Associated Infection Surveillance Network (TRANSNET) | Transplant Infectious Disease | 2014 | 133 |
| 19 | Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir | Transplant Infectious Disease | 2007 | 128 |
| 20 | The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach | Transplant Infectious Disease | 2001 | 127 |
| 21 | Cryptococcal meningitis: an analysis among 5521 consecutive organ transplant recipients | Transplant Infectious Disease | 2002 | 126 |
| 22 | Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin A | Transplant Infectious Disease | 2004 | 125 |
| 23 | Blastomycosis in solid organ transplant recipients | Transplant Infectious Disease | 2007 | 124 |
| 24 | Infection in solid organ transplantation | Transplant Infectious Disease | 1999 | 123 |
| 25 | Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study | Transplant Infectious Disease | 2003 | 123 |
| 26 | Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10‐year, single‐center experience | Transplant Infectious Disease | 2013 | 120 |
| 27 | Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients | Transplant Infectious Disease | 1999 | 119 |
| 28 | Epidemiology of fungal infections in solid organ transplant patients | Transplant Infectious Disease | 1999 | 118 |
| 29 | Infections after T‐replete haploidentical transplantation and high‐dose cyclophosphamide as graft‐versus‐host disease prophylaxis | Transplant Infectious Disease | 2015 | 118 |
| 30 | Infections of the central nervous system in transplant recipients | Transplant Infectious Disease | 2000 | 116 |
| 31 | Etiologic agents of diarrhea in solid organ recipients | Transplant Infectious Disease | 2007 | 116 |
| 32 | Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis | Transplant Infectious Disease | 2009 | 116 |
| 33 | Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients | Transplant Infectious Disease | 2010 | 116 |
| 34 | Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipients | Transplant Infectious Disease | 2009 | 115 |
| 35 | The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis | Transplant Infectious Disease | 2001 | 114 |
| 36 | Hospitalizations for fungal infections after renal transplantation in the United States | Transplant Infectious Disease | 2001 | 114 |
| 37 | Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis | Transplant Infectious Disease | 2002 | 114 |
| 38 | Multidrug resistant gram‐negative bacilli as predominant bacteremic pathogens in liver transplant recipients | Transplant Infectious Disease | 2009 | 114 |
| 39 | Polyomavirus-associated nephropathy: update on BK virus-specific immunity | Transplant Infectious Disease | 2006 | 113 |
| 40 | Rapid diagnosis of invasive aspergillosis by antigen detection | Transplant Infectious Disease | 2003 | 112 |
| 41 | Non‐tuberculous mycobacterial infection among lung transplant recipients: a 15‐year cohort study | Transplant Infectious Disease | 2012 | 112 |
| 42 | Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis | Transplant Infectious Disease | 2000 | 110 |
| 43 | Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation | Transplant Infectious Disease | 2009 | 110 |
| 44 | Variation in antifungal prophylaxis strategies in lung transplantation | Transplant Infectious Disease | 2006 | 108 |
| 45 | Incidence, risk factors, and outcome of bloodstream infections during the pre‐engraftment phase in 521 allogeneic hematopoietic stem cell transplantations | Transplant Infectious Disease | 2014 | 107 |
| 46 | Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation | Transplant Infectious Disease | 2009 | 106 |
| 47 | Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area | Transplant Infectious Disease | 2002 | 105 |
| 48 | Infectious complications of lung transplantation | Transplant Infectious Disease | 2001 | 104 |
| 49 | A multicenter study of histoplasmosis and blastomycosis after solid organ transplantation | Transplant Infectious Disease | 2012 | 104 |
| 50 | Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability | Transplant Infectious Disease | 1999 | 101 |
